Newsroom

Fruchtkörper von Myxobakterien unter dem Lichtmikroskop

News

Pharma-backed incubator INCATE selected the HZI start-up project Myxobiotics as one of the first start-ups to get support. Myxobiotics develops a new class of antibiotics against Acinetobacter baumannii, which causes severe, difficult-to-treat respiratory infections. Myxobiotics’ approach is based on a new class of natural compounds (cystobactamids) discovered and developed as antibacterial agents by Prof Rolf Müller and Prof Mark Brönstrup and their teams at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Helmholtz Centre for Infection Research (HZI), together with Dr Thomas Hesterkamp and Evotec. The HIPS is a site of the HZI in collaboration with Saarland University.

04.02.2022

HZI Campus

HIPS

News

The Minister President of Lower Saxony, Stephan Weil, visited the Helmholtz Centre for Infection Research (HZI) today, 4 February 2022. The visit focused on the current challenges and innovative approaches, especially in combating the SARS-CoV-2 pandemic, and the future development of infection research in Lower Saxony. He also delivered a message of thanks to the scientists at the research centre in Braunschweig.

04.02.2022

HZI Campus

News

Viruses are mostly encountered as pathogens. However, virus-based vaccination platforms can also help to provide protection from different diseases. In a mouse model, researchers from the Helmholtz Centre for Infection Research (HZI) in Braunschweig together with national and international partners including the German Center for Infection Research (DZIF), the German Primate Center – Leibniz Institute for Primate Research (DPZ), the Technische Universität Braunschweig and the University of Rijeka, Croatia, have developed a novel cytomegalovirus-based vaccine against different respiratory viruses. A single dose of the vaccine that consists of a cytomegalovirus that incorporates genes from coronavirus or influenza A efficiently protected mice from the respiratory infections. The results on the vaccine candidate, which is not yet market-ready, were published in the journal Cellular & Molecular Immunity.

17.01.2022

HZI Campus

News

Principal Investigator Mathias Munschauer aims to better understand SARS-CoV-2. He now receives funding of 1.5 million euros for his research project “COVIDecode” from the European Research Council (ERC). Munschauer is the third scientist at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg to be awarded an ERC grant.

10.01.2022

HIRI

News

Silke Tannapfel, former Administrative Director, will leave the Helmholtz Centre for Infection Research (HZI) in Braunschweig on 31 December 2021 to take on new professional challenges as Ministerial Director in the Hessian Ministry of Higher Education, Research and the Arts. Elisabeth Gerndt, authorised signatory and head of the Finance and Controlling Department at the HZI, is taking over the position of acting Administrative Director.

15.12.2021

HZI Campus

News

The increasing spread of resistant germs means that formerly highly effective antibiotics are often not successful anymore in treating infectious diseases. To counteract this development, the team led by Prof. Anna Hirsch from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) has developed new drug candidates that are able to render one of the most important hospital germs harmless. The researchers have published their results in the journal Angewandte Chemie.

14.12.2021

HIPS

Back to the first page
...
58
59
60
61
...
160

HZI in the media

Infos: Herpesviren – Eine große Familie Helmholtz Zentrum für Infektionsforschung www.helmholtz-hzi.de/wissen/wissensportal/ ...

25.08.2026

SWR4 Rheinland-Pfalz

An einer weiteren Station veranschaulicht das Helmholtz-Institut für Pharmazeutische Forschung, wie die Entwicklung neuer ...

25.08.2026

MSN Deutschland

Technologien“ im HUMAN-Projekt am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig . Im Mittelpunkt ihrer Arbeit steht ...

23.08.2026

Regional Heute

... Medizinischen Hochschule Hannover (MHH) und des Helmholtz-Zentrums für Infektionsforschung (HZI). Dafür setzten die Forschenden sechs ...

19.08.2026

Pharmazeutische Zeitung

... Arbeiten am Universitätsklinikum Köln und am Helmholtz-Zentrum für Infektionsforschung startet nun die Entwicklung und GMP- ...

19.08.2026

DeutschesGesundheitsPortal

available genomic resources. HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University.

14.08.2026

News Medical

... verfügbaren genomischen Ressourcen erheblich. HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung in Zusammenarbeit ...

12.08.2026

DeutschesGesundheitsPortal

Ein Forschungsteam am Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) hat nun eine Reihe synthetischer ...

07.08.2026

ZMK - Zahnheilkunde Management Kultur

des HIRI kooperieren hierbei mit dem Helmholtz-Zentrum für Infektionsforschung (HZI) und dem Helmholtz-Institut für One Health (HIOH). Ein

06.08.2026

Börse Express

... beschleunigen

Das DFKI hat zusammen mit dem Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS), der ...

02.08.2026

SR Saarländischer Rundfunk

... Forschungszentrum Fahrzeugtechnik (NFF) oder dem Helmholtz-Zentrum für Infektionsforschung (HZI).

Am 24. März 19973 ...

01.08.2026

t-online.de

... including to Germany, for further testing. Professor Fabian Leendertz at the Helmholtz Institute for One ...

31.07.2026

Deutsche Welle

Register now for the HZI newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.